These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2650252)

  • 21. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
    Fehrman I
    Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney transplantation from living related donors.
    Mouquet C; Benalia H; Barrou B; Ourahma S; Luciani J; Coriat P; Bitker MO
    Transplant Proc; 1996 Oct; 28(5):2801. PubMed ID: 8908065
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined report on regular dialysis and transplantation in Europe, V, 1974.
    Brunner FP; Giesecke B; Gurland HJ; Jacobs C; Parsons FM; Schärer K; Seyffart G; Spies G; Wing AJ
    Proc Eur Dial Transplant Assoc; 1976; 12():2-64. PubMed ID: 778830
    [No Abstract]   [Full Text] [Related]  

  • 24. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival.
    Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcome of renal transplantation after DFPP treatment in presensitized recipients.
    Sato T; Okazaki H; Jimbo M; Iguro T; Miura K; Ishizaki M; Takahashi H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):737-8. PubMed ID: 2650249
    [No Abstract]   [Full Text] [Related]  

  • 27. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808
    [No Abstract]   [Full Text] [Related]  

  • 28. Donor specific blood transfusions do not improve graft survival in living related donor transplantation.
    Garcia VD; Kraemer ES; Prompt CA; Santos A; Caovila J; Duarte A; Filho AN; Goldani JC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined report on regular dialysis and transplantation of children in Europe, 1974.
    Schärer K; Chantler C; Brunner FP; Gurland HJ; Jacobs C; Parsons FM; Seyfart G; Wing AJ
    Proc Eur Dial Transplant Assoc; 1976; 12():65-108. PubMed ID: 778844
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of ethnicity, donor status and HLA matching on renal allograft survival: a single center study.
    Chelluri LK; Vasantha A; Ratnakar KS
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):995-7. PubMed ID: 19861859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed graft function of cadaveric renal transplants is prevented by diltiazem.
    Carmellini M; Salvadori M; Di Stefano R; Bertoni E; Nicita G; Rosati A; Taddei G; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1996 Feb; 28(1):80-2. PubMed ID: 8644348
    [No Abstract]   [Full Text] [Related]  

  • 32. Chimerism in survivors following allograft renal transplantation.
    Lee JM; Lee CJ; Hu CY; Hsieh RP; Hu RH; Lee PH; Luh SP; Lee YC; Chu SH
    Transplant Proc; 1996 Jun; 28(3):1285-7. PubMed ID: 8658662
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 35. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.
    Thistlethwaite JR; Buckingham M; Stuart JK; Gaber AO; Mayes JT; Stuart FP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):722-4. PubMed ID: 3079164
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of prospective matching for HLA-DR on renal allograft survival in a single center.
    Goeken NE; Thompson JS; Corry RJ
    Transplantation; 1981 May; 31(5):397-9. PubMed ID: 7015630
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current immunologic aspects of kidney transplantation].
    Lenhard V; Dreikorn K; Opelz G
    Urologe A; 1982 Sep; 21(5):280-9. PubMed ID: 6758280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term results after kidney transplantation].
    Rost A; Molzahn M; Brosig W; Fiedler U
    Urologe A; 1982 Sep; 21(5):299-305. PubMed ID: 6758282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.